Clinical Trial

Safety and Efficacy of Radiotherapy Combined With Immunochemotherapy in Pre-treated SCLC Patients With Liver Metastases

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is clinical trial evaluating the safety and efficacy of radiotherapy combined with immunotherapy and chemotherapy in patients with extensive-stage small-cell lung cancer (ES-SCLC) and liver metastases.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-27.
Trial Details
NCT Number NCT07258147
Lead Sponsor Sichuan University
Conditions Lung Cancer (SCLC)
Enrollment 30 participants
Start Date 2026-10-31
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-05